Company / Total Debt
PTC Therapeutics, Inc. Total Debt History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$285.4M
FY2024
5-year range
$281.9M / $571.7M
FY2020-FY2024
Trend
+0.4%
vs FY2023
Sector context
#39 of 83
Health Care
What the data says
At $285M, PTC Therapeutics, Inc.'s total debt ranks #45 of 83 in the Health Care sector. Total Debt has fluctuated over the past 9 years, ranging from $98M in FY2016 to $572M in FY2022.
Based on SEC 10-K filings.
$285M in FY2024 with a 5-year CAGR of -0.6%.
Improved from $572M to $285M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +0.4%
- 5-Year CAGR
- -0.6%
- 10-Year CAGR
- -
Sector benchmark
#45 of 83 in Health CareTop 53% of 83This company $285.4M Sector average $6.2B
▼
-95.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.6%, indicating a declining trend.
- In FY2024, total debt increased 0.4% year-over-year.
- Ranks #39 out of 83 companies in the Health Care sector.
- Peak total debt was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $285.4M | +0.4% |
| FY2023 | $284.2M | -50.3% |
| FY2022 | $571.7M | +102.8% |
| FY2021 | $281.9M | -8.8% |
| FY2020 | $309.1M | +5.2% |
| FY2019 | $293.9M | +107.9% |
| FY2018 | $141.3M | -2.5% |
| FY2017 | $145.0M | +47.6% |
| FY2016 | $98.2M | +6.9% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026